Herbal anti-inflammatory immunomodulators as host modulators in chronic periodontitis patients: a randomised, double-blind, placebo-controlled, clinical trial
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Host modulatory therapy has been proposed as a treatment for periodontal diseases. A class of herbal medicines, known to be immunomodulators, alters the activity ofimmune function through the regulation of informational molecules such as cytokines. Inthe current study, we tested the hypothesis that herbal immunomodulator drugs act as anadjuvant to scaling and root planing (SRP) in alleviating periodontal inflammation by improvingclinical and biochemical parameters. Methods: Sixty healthy subjects (30 in each group) with moderate and severe chronic periodontitiswere enrolled in a double-blind, placebo-controlled, double-masked randomisedcontrolled trial. The control group was treated with SRP and a placebo, whereas the testgroup was treated with SRP followed by dietary supplementation of Septilin for 3 weeks. Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluatedfor all patients at the baseline, 3 weeks, and 6 weeks. Results: Improved gingival index scores found in the test group as compared to the controlgroup were found to be statistically significant only after 3 weeks (P<0.001). In contrast,the decrease in the sulcus bleeding index and pocket depth scores was statistically highlysignificant in the test group as compared to the control group after 3 weeks and 6 weeks(P<0.001). However, reduced clinical attachment level and CRP scores, as reflected in thetest group as compared to the control group, were not found to be statistically significantafter both 3 weeks (P>0.05) and 6 weeks (P>0.05). Conclusions: The results of this clinical-biochemical study suggest that dietary supplementationwith herbal immunomodulatory agents may be a promising adjunct to SRP and mayaid in improving periodontal treatment outcomes.
Abstract
Purpose: Host modulatory therapy has been proposed as a treatment for periodontal diseases. A class of herbal medicines, known to be immunomodulators, alters the activity ofimmune function through the regulation of informational molecules such as cytokines. Inthe current study, we tested the hypothesis that herbal immunomodulator drugs act as anadjuvant to scaling and root planing (SRP) in alleviating periodontal inflammation by improvingclinical and biochemical parameters. Methods: Sixty healthy subjects (30 in each group) with moderate and severe chronic periodontitiswere enrolled in a double-blind, placebo-controlled, double-masked randomisedcontrolled trial. The control group was treated with SRP and a placebo, whereas the testgroup was treated with SRP followed by dietary supplementation of Septilin for 3 weeks. Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluatedfor all patients at the baseline, 3 weeks, and 6 weeks. Results: Improved gingival index scores found in the test group as compared to the controlgroup were found to be statistically significant only after 3 weeks (P<0.001). In contrast,the decrease in the sulcus bleeding index and pocket depth scores was statistically highlysignificant in the test group as compared to the control group after 3 weeks and 6 weeks(P<0.001). However, reduced clinical attachment level and CRP scores, as reflected in thetest group as compared to the control group, were not found to be statistically significantafter both 3 weeks (P>0.05) and 6 weeks (P>0.05). Conclusions: The results of this clinical-biochemical study suggest that dietary supplementationwith herbal immunomodulatory agents may be a promising adjunct to SRP and mayaid in improving periodontal treatment outcomes.
참고문헌 (40)
- Paquette DW, "Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases", Periodontol 2000, 24, pp.239~252 (2000)
- Reddy MS, "Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents: a systematic review", Ann Periodontol, 8, pp.12~37 (2003)
- Bhatavadekar NB, "New directions in host modulation for the management of periodontal disease", J Clin Periodontol, 36, pp.124~126 (2009)
- Salvi GE, "Host response modulation in the management of periodontal diseases", J Clin Periodontol, 32(Suppl 6), pp.108~129 (2005)
- Ernst E, "Prevalence of use of complementary", alternative medicine: a systematic review, 2000, pp.78, 252~257
- Spelman K, "Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators", Altern Med Rev, 11, pp.128~150 (2006)
- Kim MS, "Madimadi, Korean folk medicine, blocks TNF-alpha, IL-1beta, and IL-8 production by activated human immune cells", Cytokine, 25, pp.179~186 (2004)
- Plaeger SF, "Clinical immunology and traditional herbal medicines", Clin Diagn Lab Immunol, 10, pp.337~338 (2003)
- Udupa AL, "Wound healing profile of Septilin", Indian J Physiol Pharmacol, 33, pp.39~42 (1989)
- Praveenkumar V, "Immunopotentiating activity of septilin", Indian J Exp Biol, 35, pp.1319~1323 (1997)
- Daswani BR, "Immunomodulatory activity of septilin, a polyherbal preparation", Phytother Res, 16, pp.162~165 (2002)
- Meropol SB, "Adverse events associated with prolonged antibiotic use", Pharmacoepidemiol Drug Saf, 17, pp.523~532 (2008)
- Paraskevas S, "A systematic review and meta-analyses on C-reactive protein in relation to periodontitis", J Clin Periodontol, 35, pp.277~290 (2008)
- Gomes-Filho IS, "Chronic periodontitis and C-reactive protein levels", J Periodontol, 82, pp.969~978 (2011)
- Varma RS, "Anti-inflammatory properties of Septilin in lipopolysaccharide activated monocytes and macrophage", Immunopharmacol Immunotoxicol, 33, pp.55~63 (2011)
- Page RC, "Case definitions for use in population-based surveillance of periodontitis", J Periodontol, 78(7 Suppl), pp.1387~1399 (2007)
- Moher D, "CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials", Int J Surg, 10, pp.28~55 (2012)
- Moore CP, "Immunomodulating agents", Vet Clin North Am Small Anim Pract, 34, pp.725~737 (2004)
- Gani DK, "Evaluation of C-reactive protein and interleukin-6 in the peripheral blood of patients with chronic periodontitis", J Indian Soc Periodontol, 13, pp.69~74 (2009)
- Ide M, "Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses", J Clin Periodontol, 30, pp.334~340 (2003)
- Slade GD, "Acute-phase inflammatory response to periodontal disease in the US population", J Dent Res, 79, pp.49~57 (2000)
- Rattazzi M, "C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?", J Hypertens, 21, pp.1787~1803 (2003)
- Soeken KL, "Herbal medicines for the treatment of rheumatoid arthritis: a systematic review", Rheumatology (Oxford), 42, pp.652~659 (2003)
- Sharma SB, "Effect of herbal preparation on immune response of immunosuppressed mice", Indian J Physiol Pharmacol, 41, pp.293~296 (1997)
- Grewal DS, "Septilin and geriforte in allergic and vasomotor rhinitis", Auris Nasus Larynx, 12, pp.95~101 (1985)
- Khanna N, "Anti-inflammatory and analgesic effect of herbal preparation: septilin", Indian J Med Sci, 55, pp.195~202 (2001)
- Shetty S, "A clinico-biochemical evaluation of the role of a herbal (Ayurvedic) immunomodulator in chronic periodontal disease: a pilot study", Oral Health Dent Manag, 12, pp.95~104 (2013)
- Ju HK, "Inhibitory effects of nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis factor-alpha production in lipopolysaccharide activated macrophages", Biol Pharm Bull, 26, pp.1375~1378 (2003)
- Van Dyke TE, "The role of the host response in periodontal disease progression: implications for future treatment strategies", J Periodontol, 64(8 Suppl), pp.792~806 (1993)
- Howell TH, "Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in beagle dogs", J Periodontal Res, 26(3 Pt 1), pp.180~183 (1991)
- Abernethy TJ, "The occurrence during acute infections of a protein not normally present in the blood: I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with c polysaccharide of pneumococcus", J Exp Med, 73, pp.173~182 (1941)
- Hedlund P, "Clinical and experimental studies on C-reactive protein (acute phase protein)", Acta Med Scand Suppl, 361, pp.1~71 (1961)
- Tillett WS, "Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus", J Exp Med, 52, pp.561~571 (1930)
- Perlman E, "An immunological and electrophoretic comparison of the antibody to c polysaccharide and the C-reactive protein of acute phase serum", J Exp Med, 77, pp.97~110 (1943)
- Mattila K, "Effect of treating periodontitis on C-reactive protein levels: a pilot study", BMC Infect Dis, 2, pp.30~ (2002)
- Iwamoto Y, "Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis", J Periodontol, 74, pp.1231~1236 (2003)
- D'Aiuto F, "Periodontitis and atherogenesis: causal association or simple coincidence?", J Clin Periodontol, 31, pp.402~411 (2004)
- D'Aiuto F, "Periodontal disease and C-reactive protein-associated cardiovascular risk", J Periodontal Res, 39, pp.236~241 (2004)
- D'Aiuto F, "Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol", J Dent Res, 84, pp.269~273 (2005)
- Montebugnoli L, "Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease", J Clin Periodontol, 32, pp.188~192 (2005)
